The primary objective is to compare the effect of NLPRT with traditional non-periodized RT (TRT) on isotonic upper and lower limb muscle strength and limb muscle endurance in patients with COPD.The secondary objectives are to compare the effect of…
ID
Source
Brief title
Condition
- Respiratory disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Isotonic strength and endurance: Isotonic maximal strength (1 repetition
maximum [1RM]) and endurance test (max number of repetitions performed at 45%
of 1 RM) for leg press, shoulder flexion, calf-press and chest-press.
Secondary outcome
unctional performance performance will be evaluated by the endurance shuttle
walk test (ESWT) performed in accordance to published guidelines, and reported
in meters or seconds. The incremental shuttle walk test (ISWT) will be
performed in order to determine the correct walking speed for the ESWT, i.e.
85% ISWT speed.
The 60STS test is a reliable, valid and responsive tool for measuring
functional exercise capacity in patients with COPD.
UULEX test is a reproducible and acceptable exercise that can be used as a
simple method to evaluate upper limb function in patients with COPD.
Isometric quadriceps strength and endurance will also be performed since the
different techniques (isotonic vs isometric) might differ with regard to
clinical relevance and responsiveness.
Disease-specific health related quality of life will be assessed with the
self-administered version of the chronic respiratory questionnaire (CRQ-SA).
The CRQ-SA is a widely used disease specific questionnaire to assess symptoms
in patients with COPD. The CRQ is valid and responsive to treatment, and has
previously been used to evaluate the effects of resistance training and
nonlinear periodized exercise training in patients with COPD.
The Borg CR10 will be used to quantify the level of dyspnea during exercise
training and tests while general dyspnea in daily life will be evaluated using
the dyspnea subscale of the CRQ.
The total amount of responders i.e. defined as a response over the known
minimal detectable change or minimal important difference for included test(s),
will be determined and compared. E.g., the minimal important difference after
rehabilitation is suggested to be 177 seconds for the ESWT and 3 repetitions
for the 60 STS.
Background summary
Chronic obstructive pulmonary disease (COPD) is a leading cause of death
worldwide. It is estimated that over 500 000 patients suffer from this disease
in the Netherlands. Although COPD is primarily a disease of the respiratory
system, a common secondary consequence is quadriceps muscle dysfunction, that
is, reduced muscle strength and/or endurance.
Limb muscle dysfunction is a heterogeneous process in patients with COPD but
this is rarely considered in the exercise training prescription. Resistance
training (RT) is the best available means to improve limb muscle function in
patients with COPD. However, the optimal RT prescription for people with COPD
with regard to improving either limb muscle strength or endurance has yet to be
determined. Current guidelines for RT in COPD mainly focus on improving muscle
strength which only reflects one aspect of limb muscle function and does not
address the issue of reduced muscle endurance. Periodized resistance training,
which represents a planned variation of RT variables (e.g., volume, intensity),
is one strategy that could be used to target muscle strength as well as muscle
endurance within the same exercise regimen. In patients with COPD, nonlinear
periodized exercise training has resulted in greater effects in exercise
capacity as well as quality of life in comparison to traditional exercise
training. However, the potential effect of utilizing the concept of nonlinear
periodized resistance training (NLPRT) in patients with COPD is less
investigated.
Study objective
The primary objective is to compare the effect of NLPRT with traditional
non-periodized RT (TRT) on isotonic upper and lower limb muscle strength and
limb muscle endurance in patients with COPD.The secondary objectives are to
compare the effect of NLPRT and TRT on functional performance, isometric
quadriceps muscle strength and endurance, quality of life, dyspnea, and the
proportion of responders for each of these variables.
Study design
This study is a prospective, randomized, controlled, parallel two-group trial.
Assessments are made in week 1 and 10. Measurements for this research project
are part of routine clinical practice: standard spirometry, bio-impedance
analysis, physical activity, functional exercise capacity (incremental and
endurance shuttle walk tests), muscle strength and endurance.
Intervention
Participants will be randomized to either NLPRT or TRT of leg press, shoulder
flexion, calf press and chest press exercises (3 times per week for 8 weeks).
The following will be similar for both the NLPRT and the TRT group.
1. All exercises will be performed using training equipment available at each
participating center. Leg press, chest press and calf press exercises will be
performed using available weight machines and the shoulder flexion exercise
will be performed using free weights.
2. Exercise order will be pre-determined: 1) leg press, 2) shoulder flexion, 3)
calf press and 4) chest press. This exercise order will be used in order to
alternate between lower and upper limb exercises and between multiple- and
single-joint exercises. All exercises will be performed bilateral.
3. Rest between exercises will be standardized to 4 minutes and all exercises
will be performed using dynamic repetitions with both concentric and eccentric
muscle actions. The speed of motion in each exercise will be controlled by the
breathing of the participant, we expect a moderate exercise velocity i.e.,
1-2:1-2 seconds in the concentric and the eccentric phase respectively.
4. All sessions will be supervised and conducted by local professionals.
5. Each session will span approximately 60 minutes including a mandatory 5
minute rest before and after the training sessions. During this time, Borg
dyspnea and general fatigue ratings, oxygen saturation and heart rate will be
collected.
6. Borg dyspnea, limb muscle fatigue and exertion ratings, the later defined as
*how heavy the exercise felt*, will be collected immediately after each set of
exercise.
7. Exercise volume for each training session = (number of repetitions per set *
sets per exercise * exercises per session) will be reported.
8. New 1 RM and multiple RM tests will be performed 3 times during the 8-week
intervention period (after session 5, 10 and 15) in order to optimize exercise
loadings. If a RM test will be lower than the prior RM a new test will be
performed prior to the next training session to minimize impact of alterations
in daily fitness.
9. No general or specific warm-up will be performed prior to commencing limb
muscle endurance protocol in the NLPRT group but a specific warm-up set of 15
repetitions using a load corresponding to 30% of 1RM prior to all strength
protocols within the NLPRT and TRT group will be performed.
Study burden and risks
The risks on any undesirable side effects of this study are very low, since
tests and interventions are part of regular care tests. The benefits of the
study are high, because the results from this study will optimize exercise
training in patients with COPD.
Soestdijkerstraatweg 129
Hilversum 1213 VX
NL
Soestdijkerstraatweg 129
Hilversum 1213 VX
NL
Listed location countries
Age
Inclusion criteria
1) age 40-89 years; 2) Diagnosis of mild to very-severe COPD based on
spirometry according the GOLD classification, 3) able to provide written
informed consent.
Exclusion criteria
1) patients with asthma as primary diagnosis; 2) neuromuscular skeletal
diseases that are unstable and/or that may contribute to exercise limitation or
any other contraindications to exercise; 3) currently participating in a
structured exercise or pulmonary rehabilitation program or been involved in
pulmonary rehabilitation in the past 6 months; 4) experienced a COPD
exacerbation in the past 6 weeks.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL68455.091.18 |